Suppr超能文献

分子流行病学:最新进展与未来方向

Molecular epidemiology: recent advances and future directions.

作者信息

Perera F P, Weinstein I B

机构信息

Division of Environmental Health Science, Joseph L.Mailman School of Public Health at Columbia University, and Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA.

出版信息

Carcinogenesis. 2000 Mar;21(3):517-24. doi: 10.1093/carcin/21.3.517.

Abstract

In 1982 we proposed the concept and a framework for implementing molecular cancer epidemiology. Here, we review progress during the past 17 years in validating and applying this approach to cancer prevention. There have been major advances, notably in the understanding of environment-susceptibility interactions in human cancer. However, a review of major findings to date reveals several urgent research needs to keep pace with the rapid evolution in knowledge of mechanisms in carcinogenesis. Although much valuable progress continues to be made in the study of carcinogens that cause direct DNA damage and are mutagenic, exogenous and endogenous carcinogens can also act by altering gene expression, cell proliferation and differentiation. The mechanisms include aberrant DNA methylation, oxidative damage, effects on metabolism of nitrogen oxide and nitrites, activation of receptors and transcription factors, cyclins and other cell cycle proteins. Sensitive, validated biomarkers are needed to detect these mechanisms in small numbers of cells, tissues or fluids. There is also increasing recognition that individual risk from carcinogen exposure varies as a function of both inherited and acquired factors. Recent advances in genomics, microassay technologies and informatics hold promise for rapid identification of polymorphic variants or changes in expression of genes influencing both response and susceptibility to carcinogens. Another emerging area of molecular epidemiology concerns the role of nutrition and specific dietary factors (including studies on antioxidants, energy metabolism, insulin and various growth factors) and the modulating effect of genetic polymorphisms. Finally, molecular epidemiology has enormous potential in cancer prevention through the early identification of 'at risk' populations and the rapid assessment of intervention efficacy. Its success in fully reaching this potential will depend on the application of validated biomarkers, with adherence to sound epidemiologic and ethical principles.

摘要

1982年,我们提出了实施分子癌症流行病学的概念和框架。在此,我们回顾过去17年中在验证和应用该方法进行癌症预防方面所取得的进展。已经取得了重大进展,尤其是在理解人类癌症中的环境易感性相互作用方面。然而,对迄今为止的主要研究结果进行回顾后发现,为跟上癌症发生机制知识的快速发展,仍有若干迫切的研究需求。尽管在研究导致直接DNA损伤并具有致突变性的致癌物方面仍在不断取得许多有价值的进展,但外源性和内源性致癌物也可通过改变基因表达、细胞增殖和分化来发挥作用。其机制包括异常的DNA甲基化、氧化损伤、对氮氧化物和亚硝酸盐代谢的影响、受体和转录因子的激活、细胞周期蛋白和其他细胞周期蛋白。需要灵敏、经过验证的生物标志物来在少量细胞、组织或体液中检测这些机制。人们也越来越认识到,致癌物暴露导致的个体风险会因遗传和后天因素而有所不同。基因组学、微量分析技术和信息学方面的最新进展有望快速识别影响对致癌物反应和易感性的基因多态性变体或基因表达变化。分子流行病学的另一个新兴领域涉及营养和特定饮食因素的作用(包括对抗氧化剂、能量代谢、胰岛素和各种生长因子的研究)以及基因多态性的调节作用。最后,分子流行病学在通过早期识别“高危”人群和快速评估干预效果来预防癌症方面具有巨大潜力。其能否充分发挥这一潜力将取决于应用经过验证的生物标志物,并遵循合理的流行病学和伦理原则。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验